Strategies for Multivessel Revascularization in Patients with Diabetes
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronary intervention (PCI). We sought to discover whether aggressive medical therapy and the use of drug-eluting stents could alter the revascularization approach for patients with diabetes and multivessel coronary artery disease. METHODS In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG. The patients were followed for a minimum of 2 years (median among survivors, 3.8 years). All patients were prescribed currently recommended medical therapies for the control of low-density lipoprotein cholesterol, systolic blood pressure, and glycated hemoglobin. The primary outcome measure was a composite of death from any cause, nonfatal myocardial infarction, or nonfatal stroke. RESULTS From 2005 through 2010, we enrolled 1900 patients at 140 international centers. The patients' mean age was 63.1±9.1 years, 29% were women, and 83% had three-vessel disease. The primary outcome occurred more frequently in the PCI group (P=0.005), with 5-year rates of 26.6% in the PCI group and 18.7% in the CABG group. The benefit of CABG was driven by differences in rates of both myocardial infarction (P<0.001) and death from any cause (P=0.049). Stroke was more frequent in the CABG group, with 5-year rates of 2.4% in t…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Impressively, these results were consistent across all prespecified subgroups.274,275,292”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“(30-day stroke rate for CABG versus PCI, 1.8% versus 0.3%274)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“as did the individual outcomes of death (16.3% versus 10.9%; P<0.05)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“the primary composite outcome of 5-year rates of death resulting from any cause, nonfatal myocardial infarction, or nonfatal stroke occurred more frequently in the PCI group (26.6% versus 18.7%; P=0.005)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“although stroke was more common after CABG (5.2% versus 2.4%; P=0.03).”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333 · cited 1×
“Of these patients, 25% have diabetes.(1,2) In the Bypass Angioplasty Revascularization Investigation (BARI) trial, patients with diabetes and multivessel disease who underwent coronaryartery bypass grafting (CABG) lived longer than did patients undergoing balloon angioplasty, a finding that led to guideline recommenda…”
BackgroundSerruys, P. W., Morice, M.-C., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M. J., Ståhle, E., Feldman, T. E., van den Brand, M., Bass, E. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804626 · Cited by 4,331 · cited 6×
“In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG.”
ResultInfluentialSelf-citationDeveloped with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
Rankin, J. (1957) · Scottish Medical Journal · doi:10.1177/003693305700200504 · Cited by 2,506
Self-citationThe SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.
Sianos, G., Morel, M., Kappetein, A. P., Morice, M., Colombo, A., Dawkins, K. D., van den Brand, M., Dyck, N. V., Russell, M. E., Mohr, F. W., et al. (2005) · PubMed · Cited by 2,293
ACC/AHA guidelines for coronary artery bypass graft surgery
Eagle, K. A., Guyton, R. A., Davidoff, R., Ewy, G. A., Fonger, J., Gardner, T. J., Gott, J. P., Herrmann, H. C., Marlow, R. A., Nugent, W. C., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00389-7 · Cited by 1,995
Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel Disease
(1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350401 · Cited by 1,531
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery
Hillis, L. D., Smith, P. K., Anderson, J. L., Bittl, J. A., Bridges, C. R., Byrne, J. G., Cigarroa, J. E., DiSesa, V. J., Hiratzka, L. F., Hutter, A. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.009 · Cited by 820
Self-citationHlatky, M. A., Boothroyd, D. B., Bravata, D. M., Boersma, E., Booth, J., Brooks, M. M., Carrié, D., Clayton, T. C., Danchin, N., Flather, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60552-3 · Cited by 735 · cited 1×
“A comprehensive meta-analysis of trials performed before the introduction of drug-eluting stents showed excess mortality after PCI, as compared with CABG, in patients with diabetes.(20) Although our study was not powered to detect a difference in all-cause mortality, we observed a significantly (P = 0.”
ResultSelf-citationInvestigators, T. B. (1997) · Circulation · doi:10.1161/01.cir.96.6.1761 · Cited by 619
Research works printed but not linked: 1
- Sianos G, 2005, EuroIntervention, 1, 219
Cited by
Items 801–900 of 999
de Almeida, A. S., Fuchs, S. C. P. C., Fuchs, F. C., Silva, A. G., Lucca, M. B., Scopel, S., & Fuchs, F. D. (2020) · Vascular Health and Risk Management · doi:10.2147/vhrm.s246963 · Cited by 9
Systematic Reviews and Meta-Analyses in Cardiac Surgery: Rules of the Road – Part 1
Gaudino, M. F. L., Fremes, S. E., Bagiella, E., Bangalore, S., Demetres, M. R., D’Ascenzo, F., Biondi‐Zoccai, G., & Franco, A. D. (2020) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2020.05.148 · Cited by 10
Aung, A.-T., Koo, C. Y., Tam, W., Chen, Z. J., Kristanto, W., Sim, H. W., Kojodjojo, P., Kofidis, T., & Lee, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-78700-9 · Cited by 9
Task Force of the SEC for the ESC Guidelines on Diabetes, P. A. C. D., Expert Reviewers for the ESC Guidelines on Diabetes, P. A. C. D., & Guideliness Committee of the SEC (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.12.003 · Cited by 11
Shigemi, K., Fuke, S., Une, D., Saku, K., Shimizu, S., Kawada, T., Shishido, T., Sunagawa, K., & Sugimachi, M. (2017) · The Journal of Physiological Sciences · doi:10.1007/s12576-017-0554-8 · Cited by 10
“triple-vessel coronary artery disease and in diabetic patients with multi-vessel disease [53, 54].”
BackgroundSpitaleri, G., Moscarella, E., Brugaletta, S., Pernigotti, A., Ortega‐Paz, L., Lara, J. G., Cequier, A. R., Íñiguez, A., Serra, A., Jiménez‐Quevedo, P., et al. (2018) · EuroIntervention · doi:10.4244/eij-d-17-00608 · Cited by 9
Taggart, D. P. (2013) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezt450 · Cited by 10
Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease
Bangalore, S., Blecker, S., & Hannan, E. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1506944 · Cited by 9
CTO PCI in Patients With Diabetes Mellitus
Roffi, M., & Iglesias, J. F. (2017) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.09.008 · Cited by 9
“Patients with DM have more extensive and complex atherosclerotic coronary artery disease (CAD) compared with individuals without DM, including higher rates of CTO lesions, multivessel disease, diffuse CAD, small vessel disease, and coronary artery calcifications (7).”
MethodInfluentialHave We Overdefined Periprocedural Myocardial Infarction to the Point of Extinction?
Serruys, P. W. J. C., Hara, H., Garg, S., & Onuma, Y. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.06.006 · Cited by 9
Update on Interventional Cardiology 2013
Hernández, F., Cuevas, J. R. R., del Blanco, B. G., & Trillo, R. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.026 · Cited by 8
7-year outcomes in diabetic patients after coronary artery bypass graft in a developing country
Pezeshki, P. S., Masoudkabir, F., Pashang, M., Vasheghani‐Farahani, A., Jalali, A., Sadeghian, S., Hosseini, K., Mansourian, S., Momtahan, S., & Karimi, A. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03279-8 · Cited by 8
“The result of this pillar study demonstrated a significantly lower incidence of adverse events in patients undergoing CABG in a follow-up period of more than five years [6].”
Resultde Miguel-Yanes, J. M., Jiménez‐García, R., Hernández‐Barrera, V., de Miguel‐Díez, J., Jiménez-Sierra, A., Zamorano‐León, J. J., Cuadrado‐Corrales, N., & López‐de‐Andrés, A. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02403-y · Cited by 9
“Instead, CABG rates stabilized over time in STEMI, possibly reflecting the use of PCI as the default procedure for initial reperfusion to treat the culprit coronary lesion on presentation at the hospital, after which, if required, the patient undergoes CABG for multivessel disease [18].”
MethodZoupas, I., Manaki, V., Tasoudis, P., Karela, N.-R., Avgerinos, D. V., & Mylonas, K. S. (2024) · Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery · doi:10.1177/15569845241296530 · Cited by 8
“32,35,36 This decrease might be explained by the fact that patients chosen for TECAB usually suffer from less severe comorbidities and are subject to more strict selection criteria than those undergoing conventional CABG.”
Takahashi, K., Otsuki, H., Zimmermann, F. M., Ding, V. Y., Engstrøm, T., Thyregod, H. G. H., Beleslin, B., Putnik, S. M., Tapp, L. D., Barker, T., et al. (2025) · JAMA Cardiology · doi:10.1001/jamacardio.2025.0095 · Cited by 10
When a meta-analysis can be really useful?
Basile, C., Villaschi, A., & Maggioni, A. P. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133423 · Cited by 10
Akın, İ., Nienaber, C. A., Richardt, G., Tölg, R., Hochadel, M., Schneider, S., Senges, J., Tebbe, U., Zeymer, U., Sabin, G., et al. (2014) · Clinical Research in Cardiology · doi:10.1007/s00392-014-0662-x · Cited by 8
Brown, M. A., Klusewitz, S. M., Elefteriades, J. A., & Prescher, L. M. (2021) · International Journal of Angiology · doi:10.1055/s-0041-1735591 · Cited by 10
Cheng, K., Hill, J. M., & de Silva, R. (2024) · Interventional Cardiology Reviews Research Resources · doi:10.15420/icr.2023.45 · Cited by 8
Agarwal, S., Tuzcu, E. M., & Kapadia, S. R. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002353 · Cited by 9
“agement of Multivessel Disease (FREEDOM)—have influenced our practice in a major way.(57,58) The primary aim of SYNTAX”
MethodResultInfluentialLadwiniec, A., & Hoye, A. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.06.174 · Cited by 8
Shiomi, H., Morimoto, T., Makiyama, T., Ono, K., Furukawa, Y., Nakagawa, Y., Kadota, K., Onodera, T., Takatsu, Y., Mitsudo, K., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.02.037 · Cited by 8
Current application and bioavailability of drug-eluting stents
Escarcega, R. O., Baker, N. C., Lipinski, M. J., Magalhães, M. A., Minha, S., Omar, A., Torguson, R., & Waksman, R. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.888054 · Cited by 8
“The Strategies for Multivessel Revascularization in Patients with Diabetes (FREEDOM) trial [90], a multicenter, prospective evaluation of multivessel PCI with DES versus CABG revealed that the latter was superior to PCI, primarily due to a reduction in death and MI rates.”
BackgroundMethodLong-Term Mortality of 306,868 Patients with Multi-Vessel Coronary Artery Disease: CABG versus PCI
Efird, J. T., O’Neal, W. T., Davies, S. W., Kennedy, W. L., Alger, L., O’Neal, J. B., Ferguson, T. B., & Kypson, A. P. (2013) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2013/3380 · Cited by 8
“The FREEDOM trial, which enrolled 1,900 patients at 140 international centers, reported reduced mortality among CABG-treated patients compared with PCI [24].”
BackgroundLu, T., Lee, W.-L., Hsu, P., Lin, T. C., Sung, S., Wang, K.-L., Huang, S., Chan, W., Shih, C.-C., Lin, S., et al. (2016) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2016.01.005 · Cited by 8
“Percutaneous revascularization intervention in diabetic patients remains challenging, and the large Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM) trial demonstrated that long-term all-cause/cardiovascular death and MI occurred more frequentl…”
BackgroundInfluentialYokota, A., Gamoh, S., Tanaka-Totoribe, N., Shiba, T., Kuwabara, M., Nakamura, E., Hayase, T., Hisa, H., Nakamura, K., & Yamamoto, R. (2016) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2016.03.008 · Cited by 8
Généreux, P., Bernard, S., Palmerini, T., Caixeta, A. M., Rosner, G. F., Reiss, G. R., Xu, K., Mehran, R., & Stone, G. W. (2015) · EuroIntervention · doi:10.4244/eijy14m07_06 · Cited by 8
Harper, R. W., Nasis, A., & Sundararajan, V. (2015) · The Medical Journal of Australia · doi:10.5694/mja15.00333 · Cited by 10
McGrath, B. M., Norris, C. M., Hardwicke-Brown, E., Welsh, R. C., & Bainey, K. R. (2017) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcw055 · Cited by 11
“Table 2 represents the unadjusted mean heath status scores at baseline, 1, 3, and 5 years in DM patients with multivessel CAD according to CABG or PCI.”
ResultInfluentialSrinivasan, M. P., Kamath, P. K., Bhat, N. M., Pai, N. D., Bhat, R. U., Shah, T., Manjrekar, P., & Mahabala, C. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0237-x · Cited by 9
“However, the same magnitude of benefit has not been demonstrated in type 2 diabetes mellitus [1, 2, 19], and factors that are responsible for these new cardiovascular events have not been fully elucidated in this population.”
BackgroundRisk factors for three-vessel coronary artery disease in patients of Northwest Mexico
Arroyo‐Rodríguez, C., Brito-Zurita, O. R., Sandoval‐Navarrete, S., Solis-Vásquez, R., Ornelas-Aguirre, J. M., Olea-Hernández, C., Vásquez-Serna, C., & Castelan-Ojeda, A. M. (2018) · Archivos de cardiología de México · doi:10.1016/j.acmx.2018.02.009 · Cited by 17
“Compared with FREEDOM study, where Syntax score was 26.2 ± 8.4 (a diabetic sample with 82.8% of patients with TVCAD) 48 ; in Syntax study, the average was 28.8 ± 11.5.”
MethodInfluentialRevascularization Strategies for Non-ST-Elevation Myocardial Infarction
George, B., Misumida, N., & Ziada, K. M. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1125-9 · Cited by 8
Hommels, T. M., Hermanides, R. S., Rasoul, S., Berta, B., Ijsselmuiden, A. J. J., Jessurun, G. A. J., Benit, E., Pereira, B., Luca, G. D., & Kedhi, E. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0827-z · Cited by 9
Lee, Y., Hong, S., Kim, B., Shin, S., Suh, Y., Kim, S., Ahn, C., Kim, J., Ko, Y., Choi, D., et al. (2019) · Coronary Artery Disease · doi:10.1097/mca.0000000000000767 · Cited by 8
van der Merwe, J., Casselman, F. P. A., Vermeulen, Y., Stockman, B. A., Degrieck, I., & Praet, F. V. (2020) · Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery · doi:10.1177/1556984520920724 · Cited by 8
Short-Term Risk of Bilateral Internal Mammary Artery Grafting in Diabetic Patients
Kazui, T., Lick, S. D., Hsu, C., & Bull, D. A. (2020) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2020.09.002 · Cited by 8
Impact of Diabetes Mellitus on Outcomes after High-Risk Interventional Coronary Procedures
Johannsen, L., Soldat, J., Krueger, A., Mahabadi, A. A., Dykun, I., Totzeck, M., Jánosi, R. A., Rassaf, T., & Al‐Rashid, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113414 · Cited by 7
“It should be noted that with respect to the primary outcome, there was an early hazard of CABG, and survival curves separated in favor of CABG at approximately two years [28].”
BackgroundMethodPercutaneous Transluminal Angioplasty and Balloon Catheters
Majeed, H., & Chowdhury, Y. S. (2021) · StatPearls · Cited by 8
Shah, A., Siddiqui, E., Cuenca, C., Drotar, P., Okoh, A. K., Salemi, A., Waxman, S., & Sambol, J. T. (2021) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29649 · Cited by 8
Reynolds, M. R., Gong, T., Li, S., Herzog, C. A., & Charytan, D. M. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019391 · Cited by 8
“The comparative effectiveness of medical therapy, PCI, and CABG for CAD has been studied in several randomized trials 6,24– 26 and large-scale observational studies.”
NEF, H. M., Achenbach, S. S., Birkemeyer, R., Bufe, A., Dörr, O., Elsässer, A., Gaede, L., Gori, T., Hoffmeister, H. M., Hofmann, F. J., et al. (2021) · Der Kardiologe · doi:10.1007/s12181-021-00504-6 · Cited by 13
Rocha, R. V., Fang, J., Tam, D. Y., Elbatarny, M., Austin, P. C., Gaudino, M. F. L., Lee, D. S., & Fremes, S. E. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.12.026 · Cited by 11
d’Entremont, M.-A., Yagi, R., Salia, S., Zhang, S., Shaban, L., Bene-Alhasan, Y. O., Papatheodorou, S., Couture, É. L., Huynh, T. T., Nguyen, M. T., et al. (2022) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-022-01795-w · Cited by 8
“Several trials have demonstrated CABG to be superior to PCI in DM patients with multivessel disease without left main coronary artery disease (LMCAD) [2, 3].”
BackgroundDaoulah, A., Elfarnawany, A., Garni, T. A., Hersi, A. S., Alshehri, M., Almahmeed, W. A., Yousif, N., Abuelatta, R., Alasmari, A. S., Elsheikh-Mohamed, N. E., et al. (2022) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2022.08.002 · Cited by 8
Ram, E., Fisman, E. Z., Tenenbaum, A., Iakobishvili, Z., Peled, Y., Raanani, E., & Sternik, L. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01595-5 · Cited by 8
“In diabetic patients with coronary artery disease (CAD), the superiority of coronary artery bypass grafting (CABG) over percutaneous coronary intervention (PCI) has been demonstrated in several studies world-wide [2, 3], and is the standard treatment of choice and preferred revascularization strategy recommended by th…”
BackgroundExternal stenting for saphenous vein grafts in coronary artery bypass grafting: A meta‐analysis
Chen, H., Wang, Z., Si, K., Wu, X., Ni, H., Tang, Y., Liu, W., & Wang, Z. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.14046 · Cited by 8
Less Invasive and Hybrid Surgical/Interventional Coronary Disease Management: The Future Is Now
Ruel, M., Gupta, S., Ponnambalam, M., & Chong, A. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.11.043 · Cited by 8
EASD, E. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0289 · Cited by 13
Percutaneous coronary intervention in diabetic patients: should choice of stents be influenced?
Harskamp, R. E., & Park, D. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.13.38 · Cited by 8
Ecclestone, T., Yeates, D., & Goldacre, M. J. (2015) · Diabetic Medicine · doi:10.1111/dme.12770 · Cited by 9
Ahluwalia, A. I., Baliarsinha, A. K., Gupta, S. B., Muruganathan, A., & Das, A. K. (2014) · PubMed · Cited by 10
Andreas, M., Wiedemann, D., Stasek, S., Kampf, S., Ehrlich, M. P., Eigenbauer, E., Laufer, G., & Kocher, A. A. (2013) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivt224 · Cited by 8
“The FREEDOM trial revealed a significant survival benefit of CABG compared with PCI for diabetic patients [2].”
Impact of myocardial ischemia on myocardial revascularization in stable ischemic heart disease
Torosoff, M. T., Sidhu, M. S., & Boden, W. E. (2013) · Herz · doi:10.1007/s00059-013-3824-0 · Cited by 8
Garg, P., Kamaruddin, H., Iqbal, J., & Wheeldon, N. M. (2015) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401509010099 · Cited by 8
Coronary Stents in Diabetic Patients: State of the Knowledge
Codner, P., Gurm, H. S., & Motivala, A. A. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0837-y · Cited by 8
Misumida, N., Ahmed, A. E., Barlow, M., Goodwin, R. P., Goodwin, E., Musa, A. Z., Mathbout, M. F., Ogunbayo, G. O., Kim, S. M., Abdel‐Latif, A., et al. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.04.010 · Cited by 8
Al-Hijji, M. A., Sabbagh, A. E., & Holmes, D. R. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2018.0078 · Cited by 9
Rodríguez‐Olivares, R., Menéndez, J. L., Barca, L. V., Hycka, J. M., Hernández‐Antolín, R., Stuart, J. R.-R., & Gómez, J. L. Z. (2018) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2018.06.007 · Cited by 8
On-Pump Coronary Artery Bypass Graft: The State of the Art
Cuminetti, G., Bonadei, I., Vizzardi, E., Sciatti, E., & Lorusso, R. (2019) · Reviews on Recent Clinical Trials · doi:10.2174/1574887114666190301142114 · Cited by 11
Ram, E., Raanani, E., Klempfner, R., Peled, Y., Sternik, L., & Segev, A. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.04.170 · Cited by 8
Diabetes and Incomplete Revascularisation in ST Elevation Myocardial Infarction
Burgess, S. N., Juergens, C., Nguyen, T. L., Leung, M., Robledo, K. P., Thomas, L., Mussap, C., Lo, S. T., & French, J. K. (2020) · Heart Lung and Circulation · doi:10.1016/j.hlc.2020.09.928 · Cited by 8
Kite, T. A., Ladwiniec, A., Owens, C. G., Chase, A. J., Shaukat, A., Mozid, A. M., O’Kane, P. D., Routledge, H., Perera, D., Jain, A., et al. (2021) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29702 · Cited by 10
“008 when compared to BCIS) further supports this notion, since the FREEDOM trial demonstrated superiority of CABG over PCI in patients with MVD plus diabetes.(13) Moreover, where the robustly validated SYNTAX II Score(14) was calculated in our ReVR patients (n = 202), predicted mean 4-year mortality following PCI was…”
ResultApplication of appropriate use criteria for percutaneous coronary intervention in Japan
Inohara, T., Kohsaka, S., Ueda, I., Yagi, T., Numasawa, Y., Suzuki, M., Maekawa, Y., & Fukuda, K. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i8.463 · Cited by 8
Coronary Artery Bypass Grafting
Al‐Atassi, T., Toeg, H. D., Chan, V., & Ruel, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-24126-7.00088-0 · Cited by 15
Historical Milestones in the Management of Stable Coronary Artery Disease over the Last Half Century
Weintraub, W. S., Taggart, D. P., Mancini, G. B. J., Brown, D., & Boden, W. E. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.05.039 · Cited by 8
Kereiakes, D. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.034 · Cited by 8
ESC/EACTS guidelines on myocardial revascularization post-SYNTAX
Mohr, F. W., & Davierwala, P. M. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu346 · Cited by 8
“and all-cause mortality [18].”
Marso, S. P., & McGuire, D. K. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.07.022 · Cited by 8
“drug-eluting stents versus coronary artery bypass grafting (CABG) (2,3).”
BackgroundMethodSabik, J. F. (2016) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.08.002 · Cited by 8
Coronary revascularization in diabetic patients with chronic kidney disease
Alfonso, F., & Rivero, F. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw453 · Cited by 8
Somsen, Y., Rissanen, T. T., Hoek, R., Ris, T. H., Stuijfzand, W. J., Nap, A., Kleijn, S. A., Henriques, J. P. S., de Winter, R. W., & Knaapen, P. (2024) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.31316 · Cited by 7
“Although CABG is preferred in certain cases (e.g., complex multivessel disease [MVD] or LM CAD) [33, 34], there remains a proportion of patients who are ineligible for surgery and in whom invasive treatment is deemed appropriate.”
de Vasconcelos, N. N. B., Queiroz, V. N. F., de Souza, G. M., Mangini, S., Morita, F., da Costa, L. G. V., Campos, P. P. Z. D. A., Steffen, S. P., Takaoka, F., Neto, A. S., et al. (2025) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2025rw1353 · Cited by 9
Naito, R., Miyauchi, K., Daida, H., Morimoto, T., Hiro, T., Kimura, T., Nakagawa, Y., Yamagishi, M., Ozaki, Y., Matsuzaki, M., et al. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.31948 · Cited by 8
Nomura, T., Suzuki, N., 慎太郎, 高., Kyono, H., & Kozuma, K. (2016) · International Heart Journal · doi:10.1536/ihj.15-312 · Cited by 7
Olson, P. L., Cinelli, M., Rahming, H. S., Vazzana, T. J., Spagnola, J., Barsoum, E. A., Assaad, M., Tamburrino, F., & Lafferty, J. (2022) · Cureus · doi:10.7759/cureus.25687 · Cited by 7
“However, for certain patients, mainly those who have triple vessel disease, literature has shown that the most efficient and effective way to approach myocardial revascularization is via coronary artery bypass grafting (CABG) [1-4].”
BackgroundSong, Y., Wang, C., Tang, C., Huang, X., Wang, D., Li, R., Luo, J., Tuerxun, Y., Li, Y., Liu, B., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1249881 · Cited by 7
“In diabetic patients, the bene fi t of CABG over PCI was indicated in many studies in terms of the risk of death, non-fatal stroke, non-fatal myocardial infarction, and need for repeat revascularization (3 – 5).”
Early and long-term outcomes of less invasive approaches to coronary artery bypass surgery
Ashenhurst, C., Toubar, O., Guo, M. H., Issa, H. M. N., Ponnambalam, M., & Ruel, M. (2024) · Vessel Plus · doi:10.20517/2574-1209.2023.90 · Cited by 7
Jonik, S., Kageyama, S., Ninomiya, K., Onuma, Y., Kochman, J., Grabowski, M., Serruys, P., & Mazurek, T. (2024) · Scientific Reports · doi:10.1038/s41598-024-53905-4 · Cited by 8
Osnabrugge, R. L. J., Head, S. J., Bogers, A. J. J. C., & Kappetein, A. P. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.811977 · Cited by 8
Amsterdam, E. A., WENGER, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H. M., Kelly, R. F., Kontos, M. C., et al. (2014) · Cited by 7
Nicolini, F., Agostinelli, A., Vezzani, A., Benassi, F., & Gherli, T. (2014) · International Heart Journal · doi:10.1536/ihj.14-061 · Cited by 7
Muscle strength differ between patients with diabetes and controls following heart surgery
Boban, M., Barišić, M., Peršić, V., Zekanović, D., Medved, I., Žulj, M., & Včev, A. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.06.004 · Cited by 8
Das Herzteam bei der Planung und Durchführung von Revaskularisationen
Sinning, J., Welz, A., & Nickenig, G. (2016) · Herz · doi:10.1007/s00059-016-4477-6 · Cited by 7
Lee, P. H., Kang, S. H., Han, S., Ahn, J., Bae, J. S., Lee, C. H., Kang, S., Lee, S., Kim, Y., Lee, C. W., et al. (2017) · Coronary Artery Disease · doi:10.1097/mca.0000000000000543 · Cited by 7
Ebrahim, M. E. B. M., Dignan, R. J., Femia, G., Kim, S., Gregory, G. A., Burgess, S. N., Hee, L., Mussap, C., Aty, W., Lo, S. T., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.07.038 · Cited by 7
Tam, D. Y., Dharma, C., Rocha, R. V., Austin, P. C., Wijeysundera, H. C., Farkouh, M. E., Gaudino, M. F. L., Sadat, S., Lee, D. S., & Fremes, S. E. (2020) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.120.009082 · Cited by 7
Self-citationAkhrass, R., & Bakaeen, F. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.01.140 · Cited by 5
“The FREEDOM follow-up study showed that in patients with DM and MVD, CABG was associated with improved long-term survival and reduction in MACCE at 8 years compared with PCI and drug-eluting stents.(10,11) In this trial, 94.”
MethodShiomi, H., Morimoto, T., Furukawa, Y., Nakagawa, Y., Kadota, K., Yoshikawa, Y., Yamaji, K., Tada, T., Tazaki, J., Ehara, N., et al. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.05.015 · Cited by 7
Jensen, E. S., Olesen, K. K. W., Gyldenkerne, C., Thrane, P. G., Jensen, L. O., Raungaard, B., Poulsen, P. L., Thomsen, R. W., & Mæng, M. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02312-y · Cited by 8
“Second, CABG is superior to PCI in patients with diabetes plus obstructive multivessel disease [10, 23].”
MethodModifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization
Yamaji, K., Shiomi, H., Morimoto, T., Matsumura‐Nakano, Y., Ehara, N., Sakamoto, H., Takeji, Y., Yoshikawa, Y., Yamamoto, K., Kato, E. T., et al. (2022) · JACC Asia · doi:10.1016/j.jacasi.2021.12.012 · Cited by 7
Carvalho, P., Veiga, T. M. A., Machado, F. S. L., Porto, G. V., Pirez, J., Rivera, M., Melo, P., Braghiroli, J., & Cardoso, R. (2022) · Journal of cardiac surgery · doi:10.1111/jocs.17046 · Cited by 7
“Patients with diabetes and multivessel CAD benefit from surgical revascularization over percutaneous coronary intervention (PCI), likely due to a higher rate of in‐stent restenosis in patients with diabetes and more complete revascularization with coronary artery bypass grafting (CABG), bypassing territories which may…”
ResultLiu, J., Lin, L., Kong, Q., Ma, X., Chi, L.-Q., & Lai, Y. (2023) · Interdisciplinary CardioVascular and Thoracic Surgery · doi:10.1093/icvts/ivad092 · Cited by 10
Neurologic Events After Transcatheter Aortic Valve Replacement
Jones, B., Tuzcu, E. M., Krishnaswamy, A., & Kapadia, S. R. (2015) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2014.09.005 · Cited by 7
Suzuki, T., Asai, T., Nota, H., Kinoshita, T., Fujino, S., & Takashima, N. (2015) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.12.014 · Cited by 7
Conduits for Coronary Bypass: Arteries Other Than the Internal Thoracic Artery's
Barner, H. B. (2013) · The Korean Journal of Thoracic and Cardiovascular Surgery · doi:10.5090/kjtcs.2013.46.3.165 · Cited by 7
“Fortunately a physiologic methodology, fractional flow reserve, became available in the 1990’s and is proven for determining hemodynamic significance (flow restriction) of a stenosis and appropriateness of percutaneous intervention and coronary bypass [52-54].”
MethodKunst, G. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aeu007 · Cited by 7
Fanari, Z., Weiss, S. A., & Weintraub, W. S. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.840136 · Cited by 7
Drug-Eluting Stents in Multivessel Coronary Artery Disease: Cost Effectiveness and Clinical Outcomes
Panchal, K., Patel, S. S., & Bhatt, P. A. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/679013 · Cited by 7
“The results revealed the superiority of CABG over DES-PCI with reduced rates of death and myocardial infarction and higher rate of stroke in diabetic MVD patients at 5 year [46].”
ResultJoshi, F. R., Biasco, L., Pedersen, F., Holmvang, L., Helqvist, S., Tilsted, H., Abildgaard, U., Kelbæk, H., Lassen, J. F., Jørgensen, E. O., et al. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26598 · Cited by 7
“There are increasing data regarding the role of CABG in the management of patients with complex multi-vessel coronary artery disease and/or diabetes mellitus [1,7].”
BackgroundLoutfi, M. I., Sadaka, M. A., & Sobhy, M. A. (2016) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s37239 · Cited by 7
Metadata
- Authors
- Farkouh, M. E., Domanski, M., Sleeper, L. A., Siami, F. S., Dangas, G., Mack, M., Yang, M., Cohen, D. J., Rosenberg, Y., Solomon, S. D., Desai, A. S., Gersh, B. J., Magnuson, E. A., Lansky, A., Boineau, R., Weinberger, J., Ramanathan, K., Sousa, J. E., Rankin, J., Bhargava, B., Buse, J., Hueb, W., Smith, C. R., Muratov, V., Bansilal, S., King, S., Bertrand, M., & Fuster, V.
- Affiliations
- University of Toronto (CA)
- Icahn School of Medicine at Mount Sinai (US)
- New England Research Institutes (US)
- Cardiovascular Research Foundation (US)
- Baylor University Medical Center (US)
- University of Missouri–Kansas City (US)
- National Heart, Lung, and Blood Institute (US)
- Brigham and Women's Hospital (US)
- Mayo Clinic (US)
- Yale University (US)
- University of British Columbia (CA)
- Instituto Dante Pazzanese de Cardiologia (BR)
- Royal Perth Hospital (AU)
- All India Institute of Medical Sciences (IN)
- University of North Carolina at Chapel Hill (US)
- Universidade de São Paulo (BR)
- NewYork–Presbyterian Hospital (US)
- Université de Lille (FR)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-12-20
- Volume
- 367
- Issue
- 25
- Pages
- 2375-2384
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1946152282
- Cited by
- 1,922
- References
- 28
- Citations by year
- 2026: 75 · 2025: 85 · 2024: 75 · 2023: 97 · 2022: 132 · 2021: 127 · 2020: 130 · 2019: 120 · 2018: 135 · 2017: 150 · 2016: 182 · 2015: 201 · 2014: 207 · 2013: 181 · 2012: 17
- FWCI
- 196.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Scientific Electronic Library Online (São Paulo Research Foundation, Latin American and Caribbean Center on Health Sciences Information, Conselho Nacional de Desenvolvimento Científico e Tecnológico) (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Edwards Lifesciences
- Boston Scientific Corporation
- Insulet Corporation
- Halozyme
- Medicines Company
- Novo Nordisk
- Genentech
- St. Jude Medical
- Abbott Vascular
- National Heart, Lung, and Blood Institute (U01 01HL071988, R01HL092989, U01HL071988, U01 01HL092989, 01HL092989, 01HL071988)
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Keywords
- multivessel coronary artery disease, diabetes mellitus, coronary artery bypass grafting, percutaneous coronary intervention, drug-eluting stents, revascularization strategy, myocardial infarction, stroke, all-cause mortality, FREEDOM trial
- MeSH terms
- Aged, Coronary Artery Bypass, Cardiovascular Diseases, Coronary Artery Disease, Female, Humans, Male, Middle Aged, Myocardial Infarction, Angioplasty, Balloon, Coronary, Stroke, Diabetes Complications, Kaplan-Meier Estimate, Drug-Eluting Stents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.